Pioglitazone Improves the Insulin Sensitivity of Meal Tolerance Test in Mildly Obese Japanese Patients With Type 2 Diabetes

被引：0
|
作者：
Fujioka, Youhei
Taniguchi, Shinichi
Shiochi, Hideki
Sumi, Keisuke
Yamamoto, Naoya
Matsuzawa, Kazuhiko
Izawa, Shoichiro
Kinoshita, Hiroshi
Ohkura, Tsuyoshi
Ohkura, Hiroko
Kato, Masahiko
Yamamoto, Kazuhiro
机构：
来源：
DIABETES | 2012年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2493-PO
引用
收藏
页码：A627 / A627
页数：1
相关论文
共 50 条
  • [1] Diurnal pattern of meal tolerance and insulin sensitivity in type 2 diabetes
    Yadav, Y.
    Romeres, D.
    Cobelli, C.
    Carter, R.
    Basu, A.
    Dalla Man, C.
    Basu, R.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 129 - 130
  • [2] Pioglitazone But Not Fenofibrate Improves Insulin Sensitivity and Lipotoxicity in Obese Subjects at Risk for Diabetes
    Rasouli, Neda
    Kern, Philip A.
    DIABETES, 2012, 61 : A417 - A417
  • [3] The Mechanisms by Which Pioglitazone Improves Insulin Sensitivity and Increases Body Weight in Patients with Type 2 Diabetes Mellitus
    Hirai, Hiroyuki
    Satoh, Hiroaki
    Kudoh, Akihiro
    Hasegawa, Koji
    Yamazaki, Satoru
    Sugaya, Yoshiyuki
    Fujiwara, Makoto
    Honma, Miyuki
    Nakajima, Shinichi
    Midorikawa, Sanae
    Watanabe, Tsuyoshi
    DIABETES, 2009, 58 : A360 - A360
  • [4] Endogenous insulin secretion ability in meal tolerance test correlated with body mass index (BMI) in Japanese type 2 diabetes patients
    Tsuyoshi Ohkura
    Youhei Fujioka
    Shoichiro Izawa
    Keisuke Sumi
    Naoya Yamamoto
    Hideki Shiochi
    Kazuhiko Matsuzawa
    Hiroshi Kinoshita
    Hiroko Ohkura
    Masahiko Kato
    Shin-Ichi Taniguchi
    Kazuhiro Yamamoto
    International Journal of Diabetes in Developing Countries, 2014, 34 : 193 - 200
  • [5] Endogenous insulin secretion ability in meal tolerance test correlated with body mass index (BMI) in Japanese type 2 diabetes patients
    Ohkura, Tsuyoshi
    Fujioka, Youhei
    Izawa, Shoichiro
    Sumi, Keisuke
    Yamamoto, Naoya
    Shiochi, Hideki
    Matsuzawa, Kazuhiko
    Kinoshita, Hiroshi
    Ohkura, Hiroko
    Kato, Masahiko
    Taniguchi, Shin-Ichi
    Yamamoto, Kazuhiro
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2014, 34 (04) : 193 - 200
  • [6] Pioglitazone enhances insulin sensitivity in patients with Type 2 diabetes mellitus.
    Pavo, I
    Herz, M
    Tan, M
    Shestakova, MV
    Smirnova, OM
    Jermendy, G
    Kerenyi, Z
    Widel, MH
    Schluchter, BJ
    Johns, D
    DIABETOLOGIA, 2002, 45 : A250 - A250
  • [7] Beneficial Effects of Canagliflozin in Combination with Pioglitazone on Insulin Sensitivity in Rodent Models of Obese Type 2 Diabetes
    Watanabe, Yoshinori
    Nakayama, Keiko
    Taniuchi, Nobuhiko
    Horai, Yasushi
    Kuriyama, Chiaki
    Ueta, Kiichiro
    Arakawa, Kenji
    Senbonmatsu, Takaaki
    Shiotani, Masaharu
    PLOS ONE, 2015, 10 (01):
  • [8] Sitagliptin Improves the Impaired Acute Insulin Response during a Meal Tolerance Test in Japanese Patients with Type 2 Diabetes Mellitus: A Small-Scale Real-World Study
    Tsuyoshi Ohkura
    Youhei Fujioka
    Keisuke Sumi
    Risa Nakanishi
    Hideki Shiochi
    Naoya Yamamoto
    Kazuhiko Matsuzawa
    Shoichiro Izawa
    Hiroko Ohkura
    Masahiko Kato
    Shin-ichi Taniguchi
    Kazuhiro Yamamoto
    Diabetes Therapy, 2014, 5 : 285 - 297
  • [9] Sitagliptin Improves the Impaired Acute Insulin Response during a Meal Tolerance Test in Japanese Patients with Type 2 Diabetes Mellitus: A Small-Scale Real-World Study
    Ohkura, Tsuyoshi
    Fujioka, Youhei
    Sumi, Keisuke
    Nakanishi, Risa
    Shiochi, Hideki
    Yamamoto, Naoya
    Matsuzawa, Kazuhiko
    Izawa, Shoichiro
    Ohkura, Hiroko
    Kato, Masahiko
    Taniguchi, Shin-ichi
    Yamamoto, Kazuhiro
    DIABETES THERAPY, 2014, 5 (01) : 285 - 297
  • [10] Cerivastatin improves insulin sensitivity and insulin secretion in early-state obese type 2 diabetes
    Paniagua, JA
    López-Miranda, J
    Escribano, A
    Berral, FJ
    Marín, C
    Bravo, D
    Paz-Rojas, E
    Gómez, P
    Barcos, M
    Moreno, JA
    Pérez-Jiménez, F
    DIABETES, 2002, 51 (08) : 2596 - 2603
12345